Jiangsu Hengrui reported CNY1.05B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Cspc Pharmaceutical CNY 2.31B 299.94M Mar/2025
Kangmei Pharma CNY 1.03B 35.75M Jun/2025
Sh Fosun Pharma CNY 5.2B 282.87M Jun/2025
Sh Pharmaceutical CNY 63.15B 352.27M Jun/2025
Sino Biopharmaceutical CNY 2.49B 353.34M Dec/2024
Wuxi Apptec CNY 5.98B 405.07M Jun/2025
Zz Pientze Pharmaceu 1.94B 214.76M Jun/2025